Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for ...

Shares of inflammatory disease biotech Upstream Bio, Inc. (UPB) have rallied by roughly 60% since reporting potentially best-in-class data for its asset verekitug in a Phase 2 trial in early September ...

Upstream Bio (UPB) saw its shares move slightly in recent trading, which has caught the attention of investors keen to track shifts in the biotech sector. The company’s stock has gained 7% over the ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

ROME, Feb 4 (Reuters) - Italy's economy is ‌estimated to grow by 0.7% both this ‌year and next, the parliamentary budget watchdog UPB said on Wednesday, upgrading its 2026 estimate and slightly ...

Pack your swimsuits and join the University Program Board (UPB) on the evening of Feb. 28 for the annual Kalahari trip! UPB has reserved the entire indoor waterpark exclusively for CWRU students.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.